Margaret Garin

1.3k total citations
40 papers, 979 citations indexed

About

Margaret Garin is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Margaret Garin has authored 40 papers receiving a total of 979 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Physiology, 17 papers in Pulmonary and Respiratory Medicine and 14 papers in Surgery. Recurrent topics in Margaret Garin's work include Asthma and respiratory diseases (28 papers), Eosinophilic Esophagitis (14 papers) and Respiratory and Cough-Related Research (12 papers). Margaret Garin is often cited by papers focused on Asthma and respiratory diseases (28 papers), Eosinophilic Esophagitis (14 papers) and Respiratory and Cough-Related Research (12 papers). Margaret Garin collaborates with scholars based in United States, Germany and United Kingdom. Margaret Garin's co-authors include James Zangrilli, Steven F. Weinstein, Jonathan Corren, Lindsay Janka, Kristin B. Highland, Anne Rentoumis Cappola, Mario Castro, Kevin R. Murphy, Richard M. Silver and Charlie Strange and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Margaret Garin

39 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Margaret Garin United States	13	700	574	221	161	148	40	979
Gregory J. Beirne United States	13	75 0.1×	242 0.4×	26 0.1×	56 0.3×	57 0.4×	22	605
Thomas A. Webb United States	10	71 0.1×	103 0.2×	26 0.1×	100 0.6×	130 0.9×	18	487
L J Walsh United Kingdom	6	166 0.2×	194 0.3×	21 0.1×	58 0.4×	15 0.1×	7	593
Dylan Morris Australia	19	27 0.0×	495 0.9×	14 0.1×	372 2.3×	31 0.2×	41	787
Ahmet Hakan Ateş Türkiye	16	38 0.1×	105 0.2×	11 0.0×	151 0.9×	46 0.3×	69	738
G Lacourt Switzerland	10	94 0.1×	96 0.2×	17 0.1×	53 0.3×	13 0.1×	18	370
Max Yates United Kingdom	11	79 0.1×	275 0.5×	11 0.0×	87 0.5×	62 0.4×	41	504
Nakanobu Azuma Japan	12	79 0.1×	301 0.5×	10 0.0×	164 1.0×	42 0.3×	21	653
E. Di Cesare Italy	13	54 0.1×	104 0.2×	11 0.0×	106 0.7×	71 0.5×	23	511
Jason M. Kidd United States	15	63 0.1×	174 0.3×	11 0.0×	262 1.6×	22 0.1×	36	643

Countries citing papers authored by Margaret Garin

Since Specialization

Citations

This map shows the geographic impact of Margaret Garin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Garin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Garin more than expected).

Fields of papers citing papers by Margaret Garin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret Garin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Garin. The network helps show where Margaret Garin may publish in the future.

Co-authorship network of co-authors of Margaret Garin

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret Garin. A scholar is included among the top collaborators of Margaret Garin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret Garin. Margaret Garin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smith, John A., Surinder S. Birring, Michael S. Blaiss, et al.. (2025). Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE). American Journal of Respiratory and Critical Care Medicine. 211(6). 1038–1048. 4 indexed citations

Wechsler, Michael E., Lisa Hickey, Margaret Garin, & Anoop Chauhan. (2020). Efficacy of Reslizumab Treatment in Exacerbation-Prone Patients with Severe Eosinophilic Asthma. The Journal of Allergy and Clinical Immunology In Practice. 8(10). 3434–3442.e4. 9 indexed citations

Virchow, J. Christian, Lisa Hickey, Evelyn Du, & Margaret Garin. (2020). In patients with severe asthma with eosinophilia in reslizumab clinical trials, high peripheral blood eosinophil levels are associated with low FEV1 reversibility. Allergy Asthma and Clinical Immunology. 16(1). 26–26. 4 indexed citations

Passarell, Julie, Elizabeth Ludwig, Laura Rabinovich‐Guilatt, et al.. (2020). Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Modeling of Weight‐Based Intravenous Reslizumab Dosing. The Journal of Clinical Pharmacology. 60(8). 1039–1050. 3 indexed citations

Hickey, Lisa, Warner Carr, & Margaret Garin. (2019). Clinically meaningful improvements in asthma control questionnaire (ACQ) scores occur early, while asthma-related quality of life (AQLQ) scores continue to improve over 52 weeks, among patients with eosinophilic asthma receiving IV reslizumab. Journal of Allergy and Clinical Immunology. 143(2). AB96–AB96. 1 indexed citations

Chanez, Pascal, Lisa Hickey, Margaret Garin, & Mario Castro. (2019). Evaluation of Eosinophilic Asthma Patients Without Blood Eosinophil (EOS) Response to Intravenous (IV) Reslizumab in a Post-Hoc Analysis of 52-Week Placebo-Controlled Phase 3 Studies. Journal of Allergy and Clinical Immunology. 143(2). AB97–AB97. 2 indexed citations

Virchow, J. Christian, Rohit Katial, Guy Brusselle, et al.. (2019). Safety of Reslizumab in Uncontrolled Asthma with Eosinophilia: A Pooled Analysis from 6 Trials. The Journal of Allergy and Clinical Immunology In Practice. 8(2). 540–548.e1. 29 indexed citations

Hickey, Lisa, et al.. (2019). Multiple Components Contribute to Greater Improvements in Quality of Life with IV Reslizumab in the Most Eosinophilic Asthma Patients Compared with the Overall Patient Population. A7085–A7085. 1 indexed citations

Bateman, Eric D., Ratko Djukanović, Mario Castro, et al.. (2018). Predicting Responders to Reslizumab after 16 Weeks of Treatment Using an Algorithm Derived from Clinical Studies of Patients with Severe Eosinophilic Asthma. American Journal of Respiratory and Critical Care Medicine. 199(4). 489–495. 14 indexed citations

10.

Weinstein, Steven F., Rohit Katial, Philip G. Bardin, et al.. (2018). Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps. The Journal of Allergy and Clinical Immunology In Practice. 7(2). 589–596.e3. 65 indexed citations

11.

Korenblat, Phillip E., Mirna McDonald, & Margaret Garin. (2018). Improvements In Individual Asthma Control Questionnaire (ACQ-5) Questions With Reslizumab In Patients With Inadequately Controlled Asthma and Elevated Blood Eosinophils: Pooled Analysis of Two Phase 3 Trials. Journal of Allergy and Clinical Immunology. 141(2). AB17–AB17. 1 indexed citations

12.

Zou, Linglong, Laurie Pukac, Yael Shalit, et al.. (2018). Immunogenicity assessment of intravenous administration of reslizumab in patients with asthma in phase 3 clinical studies. PA1032–PA1032. 3 indexed citations

13.

Castro, Mario, Yochai Adir, Pascal Chanez, et al.. (2018). Consistent efficacy across endpoints with reslizumab despite short term variability in blood eosinophil levels. PA1043–PA1043. 1 indexed citations

14.

Manning, Michael, Margaret Garin, Bo Jiang, & Shawn X. Sun. (2018). Impact of Reslizumab on Duration of Exacerbations in Patients with Severe Eosinophilic Asthma. Journal of Allergy and Clinical Immunology. 141(2). AB17–AB17. 1 indexed citations

15.

Corren, Jonathan, Steven F. Weinstein, Lindsay Janka, James Zangrilli, & Margaret Garin. (2016). Phase 3 Study of Reslizumab in Patients With Poorly Controlled Asthma. CHEST Journal. 150(4). 799–810. 299 indexed citations

16.

Máspero, Jorge, Joshua Jacobs, & Margaret Garin. (2016). Improvements in Asthma Quality of Life Questionnaire (AQLQ) Domains with Reslizumab in Patients with Inadequately Controlled Asthma and Elevated Blood Eosinophils. Journal of Allergy and Clinical Immunology. 137(2). AB15–AB15. 2 indexed citations

17.

Garin, Margaret, Samantha Butts, David B. Sarwer, et al.. (2016). Ghrelin is independently associated with anti-mullerian hormone levels in obese but not non-obese women with polycystic ovary syndrome. Endocrine. 55(3). 907–913. 8 indexed citations

18.

Garin, Margaret, Alice M. Arnold, Jennifer Lee, John B. Robbins, & Anne Rentoumis Cappola. (2014). Subclinical Thyroid Dysfunction and Hip Fracture and Bone Mineral Density in Older Adults: The Cardiovascular Health Study. The Journal of Clinical Endocrinology & Metabolism. 99(8). 2657–2664. 43 indexed citations

19.

Garin, Margaret, Kristin B. Highland, Richard M. Silver, & Charlie Strange. (2009). Limitations to the 6-Minute Walk Test in Interstitial Lung Disease and Pulmonary Hypertension in Scleroderma. The Journal of Rheumatology. 36(2). 330–336. 84 indexed citations

20.

Highland, Kristin B., Margaret Garin, & Kevin Brown. (2007). The Spectrum of Scleroderma Lung Disease. Seminars in Respiratory and Critical Care Medicine. 28(4). 418–429. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact